211 related articles for article (PubMed ID: 33172444)
1. Development of a multivariable prediction model to identify patients unlikely to complete a colonoscopy following an abnormal FIT test in community clinics.
Petrik AF; Keast E; Johnson ES; Smith DH; Coronado GD
BMC Health Serv Res; 2020 Nov; 20(1):1028. PubMed ID: 33172444
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of a Mailed Colorectal Cancer Screening Outreach Program in Community Health Clinics: The STOP CRC Cluster Randomized Clinical Trial.
Coronado GD; Petrik AF; Vollmer WM; Taplin SH; Keast EM; Fields S; Green BB
JAMA Intern Med; 2018 Sep; 178(9):1174-1181. PubMed ID: 30083752
[TBL] [Abstract][Full Text] [Related]
3. Colonoscopy Following an Abnormal Fecal Test Result from an Annual Colorectal Cancer Screening Program in a Federally Qualified Health Center.
Escaron AL; Garcia J; Petrik AF; Ruiz E; Nyongesa DB; Thompson JH; Coronado GD
J Prim Care Community Health; 2022; 13():21501319221138423. PubMed ID: 36448466
[TBL] [Abstract][Full Text] [Related]
4. Effect of Colonoscopy Outreach vs Fecal Immunochemical Test Outreach on Colorectal Cancer Screening Completion: A Randomized Clinical Trial.
Singal AG; Gupta S; Skinner CS; Ahn C; Santini NO; Agrawal D; Mayorga CA; Murphy C; Tiro JA; McCallister K; Sanders JM; Bishop WP; Loewen AC; Halm EA
JAMA; 2017 Sep; 318(9):806-815. PubMed ID: 28873161
[TBL] [Abstract][Full Text] [Related]
5. Patient randomized trial of a targeted navigation program to improve rates of follow-up colonoscopy in community health centers.
Coronado GD; Johnson ES; Leo MC; Schneider JL; Smith D; Mummadi R; Petrik AF; Thompson JH; Jimenez R
Contemp Clin Trials; 2020 Feb; 89():105920. PubMed ID: 31881390
[TBL] [Abstract][Full Text] [Related]
6. Comparative effectiveness of fecal immunochemical test outreach, colonoscopy outreach, and usual care for boosting colorectal cancer screening among the underserved: a randomized clinical trial.
Gupta S; Halm EA; Rockey DC; Hammons M; Koch M; Carter E; Valdez L; Tong L; Ahn C; Kashner M; Argenbright K; Tiro J; Geng Z; Pruitt S; Skinner CS
JAMA Intern Med; 2013 Oct; 173(18):1725-32. PubMed ID: 23921906
[TBL] [Abstract][Full Text] [Related]
7. Moderators of the effectiveness of an intervention to increase colorectal cancer screening through mailed fecal immunochemical test kits: results from a pragmatic randomized trial.
O'Connor EA; Vollmer WM; Petrik AF; Green BB; Coronado GD
Trials; 2020 Jan; 21(1):91. PubMed ID: 31941527
[TBL] [Abstract][Full Text] [Related]
8. Patient-Reported Barriers to Completing a Diagnostic Colonoscopy Following Abnormal Fecal Immunochemical Test Among Uninsured Patients.
Jetelina KK; Yudkin JS; Miller S; Berry E; Lieberman A; Gupta S; Balasubramanian BA
J Gen Intern Med; 2019 Sep; 34(9):1730-1736. PubMed ID: 31228053
[TBL] [Abstract][Full Text] [Related]
9. The recalibration and redevelopment of a model to calculate patients' probability of completing a colonoscopy following an abnormal fecal test.
Petrik AF; Johnson ES; Slaughter M; Leo MC; Thompson J; Mummadi RR; Jimenez R; Hussain SA; Coronado G
J Med Screen; 2024 Mar; 31(1):28-34. PubMed ID: 37661831
[TBL] [Abstract][Full Text] [Related]
10. Timeliness of Colonoscopy After Abnormal Fecal Test Results in a Safety Net Practice.
Oluloro A; Petrik AF; Turner A; Kapka T; Rivelli J; Carney PA; Saha S; Coronado GD
J Community Health; 2016 Aug; 41(4):864-70. PubMed ID: 26874943
[TBL] [Abstract][Full Text] [Related]
11. Association Between Primary Care Visits and Colorectal Cancer Screening Outcomes in the Era of Population Health Outreach.
Halm EA; Beaber EF; McLerran D; Chubak J; Corley DA; Rutter CM; Doubeni CA; Haas JS; Balasubramanian BA
J Gen Intern Med; 2016 Oct; 31(10):1190-7. PubMed ID: 27279097
[TBL] [Abstract][Full Text] [Related]
12. Strategies and Opportunities to STOP Colon Cancer in Priority Populations: design of a cluster-randomized pragmatic trial.
Coronado GD; Vollmer WM; Petrik A; Taplin SH; Burdick TE; Meenan RT; Green BB
Contemp Clin Trials; 2014 Jul; 38(2):344-9. PubMed ID: 24937017
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic colonoscopy completion after abnormal fecal immunochemical testing and quality of tests used at 8 Federally Qualified Health Centers in Southern California: Opportunities for improving screening outcomes.
Bharti B; May FFP; Nodora J; Martínez ME; Moyano K; Davis SL; Ramers CB; Garcia-Bigley F; O'Connell S; Ronan K; Barajas M; Gordon S; Diaz G; Ceja E; Powers M; Arredondo EM; Gupta S
Cancer; 2019 Dec; 125(23):4203-4209. PubMed ID: 31479529
[TBL] [Abstract][Full Text] [Related]
14. Factors Affecting Adherence in a Pragmatic Trial of Annual Fecal Immunochemical Testing for Colorectal Cancer.
Nielson CM; Vollmer WM; Petrik AF; Keast EM; Green BB; Coronado GD
J Gen Intern Med; 2019 Jun; 34(6):978-985. PubMed ID: 30684199
[TBL] [Abstract][Full Text] [Related]
15. Inadequate Utilization of Diagnostic Colonoscopy Following Abnormal FIT Results in an Integrated Safety-Net System.
Issaka RB; Singh MH; Oshima SM; Laleau VJ; Rachocki CD; Chen EH; Day LW; Sarkar U; Somsouk M
Am J Gastroenterol; 2017 Feb; 112(2):375-382. PubMed ID: 28154400
[TBL] [Abstract][Full Text] [Related]
16. Abnormal Colorectal Cancer Test Follow-Up: A Quality Improvement Initiative at a Federally Qualified Health Center.
Shareef F; Bharti B; Garcia-Bigley F; Hernandez M; Nodora J; Liu J; Ramers C; Nery JD; Marquez J; Moyano K; Rojas S; Arredondo E; Gupta S
J Prim Care Community Health; 2024; 15():21501319241242571. PubMed ID: 38554066
[TBL] [Abstract][Full Text] [Related]
17. Outreach invitations for FIT and colonoscopy improve colorectal cancer screening rates: A randomized controlled trial in a safety-net health system.
Singal AG; Gupta S; Tiro JA; Skinner CS; McCallister K; Sanders JM; Bishop WP; Agrawal D; Mayorga CA; Ahn C; Loewen AC; Santini NO; Halm EA
Cancer; 2016 Feb; 122(3):456-63. PubMed ID: 26535565
[TBL] [Abstract][Full Text] [Related]
18. Prospective Cohort study of Predictors of Follow-Up Diagnostic Colonoscopy from a Pragmatic Trial of FIT Screening.
O'Connor EA; Nielson CM; Petrik AF; Green BB; Coronado GD
Sci Rep; 2020 Feb; 10(1):2441. PubMed ID: 32051454
[TBL] [Abstract][Full Text] [Related]
19. Reasons for Lack of Diagnostic Colonoscopy After Positive Result on Fecal Immunochemical Test in a Safety-Net Health System.
Martin J; Halm EA; Tiro JA; Merchant Z; Balasubramanian BA; McCallister K; Sanders JM; Ahn C; Bishop WP; Singal AG
Am J Med; 2017 Jan; 130(1):93.e1-93.e7. PubMed ID: 27591183
[TBL] [Abstract][Full Text] [Related]
20. Positive predictive values of fecal immunochemical tests used in the STOP CRC pragmatic trial.
Nielson CM; Petrik AF; Jacob L; Vollmer WM; Keast EM; Schneider JL; Rivelli JS; Kapka TJ; Meenan RT; Mummadi RR; Green BB; Coronado GD
Cancer Med; 2018 Sep; 7(9):4781-4790. PubMed ID: 30101513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
